Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler<sup>®</sup> Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler<sup>®</sup> Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory lung disease characterized by airflow limitation that is not completely reversible. The fixed-dose combination of salmeterol and fluticasone propionate (SFC) has been approved as a treatment for COPD patients with a history...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paschalis Steiropoulos, Stavros Tryfon, Christos Kyriakopoulos, Konstantinos Bartziokas, Konstantinos Kostikas
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COPD
FEV<sub>1</sub>
mMRC
salmeterol and fluticasone propionate fixed-dose combination
safety analysis
Medicine
R
Acceso en línea:https://doaj.org/article/b8b43807233243a88f917652da79365e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/b8b43807233243a88f917652da79365e

Ejemplares similares